MedTrace Logo

Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients

NCT04780581 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2025-01-06

Study results available
· View outcomes & findings →

Summary

Treatment with glucocorticoids in COVID patients. Low-intervention, phase IV, open-label, randomised, low-intervention clinical trial comparing 2 active treatments.

Conditions

  • Corona Virus Infection

Interventions

DRUG

Dexamethasone

6 mg/24h - 10 days

DRUG

Methylprednisolone

250 mg/ 24h - 3 days

Sponsors & Collaborators

  • Instituto de Investigación Biomédica de Salamanca

    collaborator OTHER

  • Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

    lead OTHER

Principal Investigators

  • Luis Corral Gudino · Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2021-11-09
Completion
2021-11-09

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04780581 on ClinicalTrials.gov